Counteraction by repetitive daily exposure to static magnetism against sustained blockade of N‐methyl‐D‐aspartate receptor channels in cultured rat hippocampal neurons
- 21 April 2005
- journal article
- research article
- Published by Wiley in Journal of Neuroscience Research
- Vol. 80 (4) , 491-500
- https://doi.org/10.1002/jnr.20497
Abstract
In rat hippocampal neurons cultured with the antagonist for N‐methyl‐D‐aspartate (NMDA) receptors dizocilpine (MK‐801) for 8 days in vitro (DIV), a significant decrease was seen in the expression of microtubule‐associated protein‐2 (MAP‐2) as well as mRNA for both brain‐derived neurotrophic factor (BDNF) and growth‐associated protein‐43 (GAP‐43), in addition to decreased viability. MK‐801 not only decreased the expression of the NR1 subunit of NMDA receptors but also increased NR2A expression, without affecting NR2B expression. Repetitive daily exposure to static magnetic fields at 100 mT for 15 min led to a decrease in the expression of MAP‐2, without significantly affecting cell viability or the expression of neuronal nuclei (NeuN) and GAP‐43. However, the repetitive magnetism prevented decreases in both BDNF mRNA and MAP‐2 and additionally increased the expression of NR2A subunit, without altering NR1 expression in neurons cultured in the presence of MK‐801. Repetitive magnetism was also effective in preventing the decrease by MK‐801 in the ability of NMDA to increase intracellular free Ca2+ ions, without affecting the decrease in the maximal response. These results suggest that repetitive magnetism may at least in part counteract the neurotoxicity of MK‐801 through modulation of the expression of particular NMDA receptor subunits in cultured rat hippocampal neurons.Keywords
This publication has 41 references indexed in Scilit:
- Functional alterations in immature cultured rat hippocampal neurons after sustained exposure to static magnetic fieldsJournal of Neuroscience Research, 2003
- Transcranial magnetic stimulation as a therapeutic tool in psychiatry: what do we know about the neurobiological mechanisms?Journal of Psychiatric Research, 2001
- Group III Metabotropic Glutamate Receptors in Rat Cultured Calvarial OsteoblastsBiochemical and Biophysical Research Communications, 2001
- Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorderMolecular Psychiatry, 2000
- Nicotine prevents glutamate-induced proteolysis of the microtubule-associated protein MAP-2 and glutamate neurotoxicity in primary cultures of cerebellar neuronsNeuropharmacology, 1998
- Serotonin depletion in the adult rat causes loss of the dendritic marker MAP-2: A new animal model of schizophrenia?Neuropsychopharmacology, 1995
- Ammonium Injection Induces an N‐Methyl‐d‐Aspartate Receptor‐Mediated Proteolysis of the Microtubule‐Associated Protein MAP‐2Journal of Neurochemistry, 1993
- Magnetic Fields in the Treatment Of Parkinson's DiseaseInternational Journal of Neuroscience, 1992
- NMDA Antagonist Neurotoxicity: Mechanism and PreventionScience, 1991
- Effect of striatal cells on in vitro maturation of mesencephalic dopaminergic neurones grown in serum-free conditionsNature, 1980